Table 2. Propensity score matching of preoperative variables.
Parameter | AFU (n=40) | PIFT (n=40) | P value |
---|---|---|---|
Age | 59.3±11.2 | 60.2±11.7 | 0.639** |
Gender | 0.597* | ||
Male | 7 | 8 | |
Female | 23 | 22 | |
BMI | 19.5±2.3 | 20.7±2.0 | 0.772** |
Histological type | 0.655* | ||
SC | 3 | 6 | |
AD | 37 | 34 | |
Clinical TNM Stage | 0.371* | ||
T1aN0M0 | 16 | 13 | |
T1bN0M0 | 12 | 20 | |
T1cN0M0 | 12 | 17 | |
Tumor size | 0.371* | ||
<1 cm | 16 | 13 | |
1–2 cm | 12 | 20 | |
2–3 cm | 12 | 17 | |
Pulmonary Function | 0.842** | ||
FEV1% | 75.4±11.6 | 77.6±12.1 | |
DLCO% | 65.6±12.7 | 64.7±11.8 | |
Fissure grade | |||
III | 34 | 35 | 0.883* |
IV | 6 | 5 | 0.778* |
Comorbidity | |||
Primary hypertension | 15 | 12 | 0.685* |
Grade I | 7 | 5 | 0.878* |
Grade II | 8 | 7 | |
II type diabetic mellitus | 8 | 7 |
Data are mean ± standard deviation or N (percentage). *, McNemar’s test; **, paired Student’s t-test. FEV1, forced expiratory volume in the first second; DLCO, diffusing capacity of carbon monoxide; SC, squamous cell cancer; AD, adenocarcinoma; AFU, anterior fissureless uniport: PIFT, posterior intra-fissure triple-port; BMI, body mass index.